Aim: In this report a 10-year follow-up of Japanese multicentre trial of re
nal transplantation using cyclosporine is described. Material and methods:
A total of 1,323 recipients, including 1,055 (79.7%) living donor (LD) tran
splantations and 268 (20. 3%) non-heart-beating cadaveric donor (CD) transp
lantations, were enrolled in the study. Results: Favorable results; graft s
urvival at 1, 5 and 10 years were 95.8%, 80.9%, 56.8%, respectively, for LD
, and 88.7%, 74.2%, 58.8%, respectively, even for CD, were obtained. No ser
ious adverse reactions or complications were observed in this group of pati
ents excepting 28 cases (2.0%) of malignant tumors. There were no cases of
abnormality in 39 babies delivered during the term. Conclusion: We demonstr
ate the interesting findings that graft survival of non-heart-beating CD ar
e surprisingly as good as that of LD and the safety issues are almost equal
to other available data in other countries.